Concepedia

Luning Zhuang

LZ

Statistics

Publications

15

Citations

566

H-Index

13

Active since

2011

Affiliations

University of Florida(Current)

AstraZeneca (United States)

United States Food and Drug Administration

Center for Drug Evaluation and Research

American Association of Colleges of Pharmacy

Luning Zhuang is an author at University of Florida specializing in pharmacology, pharmacokinetics of antimicrobials, and pharmacokinetics.

ORCID

Publications per year

2011–2020

15

Publications

15

FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia

Kelly J. Norsworthy, Kunthel By, Sriram Subramaniam et al. · Clinical Cancer Research · 2019 · 121 citations

, , +13

FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm

Emily Y. Jen, Xin Gao, Liang Li et al. · Clinical Cancer Research · 2019 · 91 citations

, , +13

Osimertinib for the Treatment of Metastatic EGFR T790M Mutation–Positive Non–Small Cell Lung Cancer

Sean Khozin, Chana Weinstock, Gideon M. Blumenthal et al. · Clinical Cancer Research · 2016 · 84 citations · Full text

, , +15

<i>In vitro</i>pharmacokinetics/pharmacodynamics of the combination of avibactam and aztreonam against MDR organisms

Sherwin K. B. Sy, Marie‐Eve Beaudoin, Luning Zhuang et al. · Journal of Antimicrobial Chemotherapy · 2016 · 38 citations · Full text

, , +16

Prediction of<i>in vivo</i>and<i>in vitro</i>infection model results using a semimechanistic model of avibactam and aztreonam combination against multidrug resistant organisms

Luning Zhuang, Huiming Xia, M-E Beaudoin et al. · CPT Pharmacometrics & Systems Pharmacology · 2017 · 29 citations · Full text

, , +17

1–5 of 15